Evidence map›Paper›PMID 41008118›Full record

ArticleEntropy (Basel, Switzerland)2025

Gradient-Free De Novo Learning.

Karl Friston, Thomas Parr, Conor Heins, Lancelot Da Costa, Tommaso Salvatori, Alexander Tschantz, Magnus Koudahl, Toon Van de Maele, Christopher Buckley, Tim Verbelen

Abstract read
In one paragraph

Article in Entropy (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Karl FristonQueen Square Institute of Neurology, University College London, London WC1E 6BT, UK.ORCID 0000-0001-7984-8909
Thomas ParrNuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX1 2JD, UK.ORCID 0000-0001-5108-5743
Conor HeinsVERSES Research Lab, Los Angeles, CA 90016, USA.
Lancelot Da CostaVERSES Research Lab, Los Angeles, CA 90016, USA.ORCID 0000-0003-0126-4588
Tommaso SalvatoriVERSES Research Lab, Los Angeles, CA 90016, USA.
Alexander TschantzVERSES Research Lab, Los Angeles, CA 90016, USA.
Magnus KoudahlVERSES Research Lab, Los Angeles, CA 90016, USA.
Toon Van de MaeleVERSES Research Lab, Los Angeles, CA 90016, USA.ORCID 0000-0001-7583-3291
Christopher BuckleyVERSES Research Lab, Los Angeles, CA 90016, USA.
Tim VerbelenVERSES Research Lab, Los Angeles, CA 90016, USA.ORCID 0000-0003-2731-7262

Funding

National Institute for Health Research ACF-2023-13-013Wellcome TrustWellcome Trust 205103/Z/16/Z
6 · The paper itself

Abstract

This technical note applies active inference to the problem of learning goal-directed behaviour from scratch, namely, de novo learning. By de novo learning, we mean discovering, directly from observations, the structure and parameters of a discrete generative model for sequential policy optimisation. Concretely, our procedure grows and then reduces a model until it discovers a pullback attractor over (generalised) states; this attracting set supplies paths of least action among goal states while avoiding costly states. The implicit efficiency rests upon reframing the learning problem through the lens of the free energy principle, under which it is sufficient to learn a generative model whose dynamics feature such an attracting set. For context, we briefly relate this perspective to value-based formulations (e.g., Bellman optimality) and then apply the active inference formulation to a small arcade game to illustrate de novo structure learning and ensuing agency.

Indexed as

active inferenceactive learningBayesian model selectioncompressioninductionplanningstructure learning

Identifiers

PMID41008118
PMCPMC12468873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.